Transmitted drug resistance and molecular transmission network among treatment-naive HIV-1 patients in Wenzhou, China, 2020–2023

While TDR prevalence in Wenzhou remained lower than in other Chinese regions, an upward trend was observed. Most resistant individuals were in transmission clusters, predominantly middle-aged and elderly. NNRTI resistance was severe and concentrated in efavirenz, nevirapine, and rilpivirine. Enhanced HIV surveillance and wider free antiretroviral options are crucial to control drug-resistant HIV spread in Wenzhou.

Authors

Institutions

Publication Details

Journal
Virology Journal
Published
2024-10-17
DOI
https://doi.org/10.1186/s12985-024-02528-2
Citations
4
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
1.56

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transmitted drug resistance and molecular transmission network among treatment-naive HIV-1 patients in Wenzhou, China, 2020–2023

Binbin Lv, Mingyuan Zhou, Bao‐Chang Sun, Han Tang et al.
4 citations
Virology Journal
HIV/AIDS drug development and treatment
1.56
article

Transmitted drug resistance and molecular transmission network among treatment-naive HIV-1 patients in Wenzhou, China, 2020–2023

Binbin Lv, Mingyuan Zhou, Bao‐Chang Sun, Han Tang, Tianran Zhang, Weilong Wang, Hui Ye, Haiyang Dai, Wenxue Hu, Weiqin Wang, Hong Yan Dou
article en
4 citations

Abstract

While TDR prevalence in Wenzhou remained lower than in other Chinese regions, an upward trend was observed. Most resistant individuals were in transmission clusters, predominantly middle-aged and elderly. NNRTI resistance was severe and concentrated in efavirenz, nevirapine, and rilpivirine. Enhanced HIV surveillance and wider free antiretroviral options are crucial to control drug-resistant HIV spread in Wenzhou.

Virology JournalVol. 21(1)
Wenzhou Central Hospital (CN), Wenzhou Municipal Sci-Tech Bureau (CN), Wenzhou Institute of Technology Testing & Calibration (CN)
Wenzhou Municipal Science and Technology Bureau
Good health and well-being
Openalex Percentile: Top 17%
HIV/AIDS drug development and treatment
1.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Transmitted drug resistance and molecular transmission network among treatment-naive HIV-1 patients in Wenzhou, China, 2020–2023 — Binbin Lv, Mingyuan Zhou, et al. · Virology Journal (2024) | TGRS Research Map | TGRS